XD9E:XETRA:XETRA-Xtrackers MSCI USA UCITS ETF 2C - EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 122.38

Change

+0.24 (+0.19)%

Market Cap

USD 0.27B

Volume

1.83K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.80 (-1.54%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.33 (-1.97%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.46%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.13 (-0.44%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.23 (-0.93%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.23 (-0.49%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-0.86 (-0.60%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.28 (-0.54%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.39 (+0.37%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.70 (+0.45%)

USD 80.38B

ETFs Containing XD9E:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.71% 83% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.71% 83% B 82% B
Trailing 12 Months  
Capital Gain 32.74% 84% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.74% 84% B 83% B
Trailing 5 Years  
Capital Gain 85.03% 90% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 85.03% 89% A- 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 13.95% 82% B 79% B-
Dividend Return 13.95% 81% B- 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.58% 20% F 33% F
Risk Adjusted Return 71.24% 67% D+ 71% C-
Market Capitalization 0.27B 51% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.